News

Home
Manufacturing
Manufacturing
OEM Manufacturing
Quality Control
About the Factory
About the Factory
Our History
Management
Certificates
Partners
Licenses
Achievements
Special Evaluation of Labour Conditions
Videos
News
Products
Contacts
Contacts
Quality Claims

News

Details: Published: 06 September 2013

On September 9, Medsintez, the Novouralsk plant, will release its first lot of the Aveloks antibiotic. As Alexander Petrov (Jr.), Chairman of Medsintez's Board of Directors, told the EAN agency, the manufacturing of this new-generation drug is carried out according to the agreement signed with the plant's strategic partner, Bayer (Germany).

Details: Published: 20 August 2013

In Q4 2013, the Medsintez plant, for the first time in Russia, will begin to produce disposable insulin syringe pens for patients with diabetes mellitus. The price of a set of five pens will be approximately 600-700 roubles; a similar set from a foreign manufacturer costs 800 roubles. On prescription, residents of the Sverdlovsk region will be able to get them for free.

Details: Published: 02 November 2012

"The signed strategic agreement includes the results of months of collaboration between the two companies.

Details: Published: 02 November 2012

In 2013, Bayer (the Russian division of Bayer AG) will launch the drug production on the premises of Medsintez, an Ural plant, as Alexander Petrov, Chairman of Medsintez's Board of Directors has told.

Details: Published: 11 February 2009

Download

Page 8 of 9

Start
Prev
1
2
3
4
5
6
7
8
9
Next
End

+7 (34370) 2-50-61

+7 (34370) 2-54-95

Torgovaya 15, Novouralsk, Sverdlovsk region, Russia, 624130

Contacts

News

Medsintez Launches Production of an Antibiotic for Tuberculosis

It Was Decided to Produce Insulin Syringe Pens at the Medsintez Plant

In 2013, Bayer Is Going to Launch Drug Manufacturing at the Ural Medsintez Plant

Bayer and Medsintez Are Going to Establish a JV in Urals

Implementation and Certification of an Integrated Management System in a Pharmaceutical Company